4.6 Article

Novel Role for Pendrin in Orchestrating Bicarbonate Secretion in Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)-expressing Airway Serous Cells

期刊

JOURNAL OF BIOLOGICAL CHEMISTRY
卷 286, 期 47, 页码 41069-41082

出版社

AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.M111.266734

关键词

-

资金

  1. Biotechnology and Biological Sciences Research Council [BBS/S/M/2006/13134]

向作者/读者索取更多资源

In most HCO3--secreting epithelial tissues, SLC26 Cl-/HCO3- transporters work in concert with the cystic fibrosis transmembrane conductance regulator (CFTR) to regulate the magnitude and composition of the secreted fluid, a process that is vital for normal tissue function. By contrast, CFTR is regarded as the only exit pathway for HCO3- in the airways. Here we show that Cl-/HCO3- anion exchange makes a major contribution to transcellular HCO3- transport in airway serous cells. Real-time measurement of intracellular pH from polarized cultures of human Calu-3 cells demonstrated cAMP/PKA-activated Cl--dependent HCO3- transport across the luminal membrane via CFTR-dependent coupled Cl-/HCO3- anion exchange. The pharmacological and functional profile of the luminal anion exchanger was consistent with SLC26A4 (pendrin), which was shown to be expressed by quantitative RT-PCR, Western blot, and immunofluorescence. Pendrin-mediated anion exchange activity was confirmed by shRNA pendrin knockdown (KD), which markedly reduced cAMP-activated Cl-/HCO3- exchange. To establish the relative roles of CFTR and pendrin in net HCO3- secretion, transepithelial liquid secretion rate and liquid pH were measured in wild type, pendrin KD, and CFTR KD cells. cAMP/PKA increased the rate and pH of the secreted fluid. Inhibiting CFTR reduced the rate of liquid secretion but not the pH, whereas decreasing pendrin activity lowered pH with little effect on volume. These results establish that CFTR predominately controls the rate of liquid secretion, whereas pendrin regulates the composition of the secreted fluid and identifies a critical role for this anion exchanger in transcellular HCO3- secretion in airway serous cells.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Neurosciences

Hypercapnia modulates cAMP signalling and cystic fibrosis transmembrane conductance regulator-dependent anion and fluid secretion in airway epithelia

Mark J. Turner, Vinciane Saint-Criq, Waseema Patel, Salam H. Ibrahim, Bernard Verdon, Christopher Ward, James P. Garnett, Robert Tarran, Martin J. Cann, Michael A. Gray

JOURNAL OF PHYSIOLOGY-LONDON (2016)

Review Respiratory System

Airway surface liquid homeostasis in cystic fibrosis: pathophysiology and therapeutic targets

Iram J. Haq, Michael A. Gray, James P. Garnett, Christopher Ward, Malcolm Brodlie

THORAX (2016)

Review Biochemistry & Molecular Biology

Role of CFTR in epithelial physiology

Vinciane Saint-Criq, Michael A. Gray

CELLULAR AND MOLECULAR LIFE SCIENCES (2017)

Article Physiology

CK2 is a key regulator of SLC4A2-mediated Cl-/HCO3 - exchange in human airway epithelia

Salam H. Ibrahim, Mark J. Turner, Vinciane Saint-Criq, James Garnett, Iram J. Haq, Malcolm Brodlie, Chris Ward, Christian Borgo, Mauro Salvi, Andrea Venerando, Michael A. Gray

PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2017)

Article Multidisciplinary Sciences

The Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Uses its C-Terminus to Regulate the A2B Adenosine Receptor

Michael J. Watson, Shernita L. Lee, Abigail J. Marklew, Rodney C. Gilmore, Martina Gentzsch, Maria F. Sassano, Michael A. Gray, Robert Tarran

SCIENTIFIC REPORTS (2016)

Article Biochemistry & Molecular Biology

Increases in cytosolic Ca2+ induce dynamin- and calcineurin-dependent internalisation of CFTR

Waseema Patel, Patrick J. Moore, M. Flori Sassano, Miqueias Lopes-Pacheco, Andrei A. Aleksandrov, Margarida D. Amaral, Robert Tarran, Michael A. Gray

CELLULAR AND MOLECULAR LIFE SCIENCES (2019)

Editorial Material Neurosciences

Location, location, location: lessons from airway epithelial anion channels

Livia Delpiano, Michael A. Gray

JOURNAL OF PHYSIOLOGY-LONDON (2019)

Article Chemistry, Medicinal

Achieving In Vivo Target Depletion through the Discovery and Optimization of Benzimidazolone BCL6 Degraders

Benjamin R. Bellenie, Kwai-Ming J. Cheung, Ana Varela, Olivier A. Pierrat, Gavin W. Collie, Gary M. Box, Michael D. Bright, Sharon Gowan, Angela Hayes, Matthew J. Rodrigues, Kartika N. Shetty, Michael Carter, Owen A. Davis, Alan T. Henley, Paolo Innocenti, Louise D. Johnson, Manjuan Liu, Selby de Klerk, Yann-Vai Le Bihan, Matthew G. Lloyd, P. Craig McAndrew, Erald Shehu, Rachel Talbot, Hannah L. Woodward, Rosemary Burke, Vladimir Kirkin, Rob L. M. van Montfort, Florence Raynaud, Olivia W. Rossanese, Swen Hoelder

JOURNAL OF MEDICINAL CHEMISTRY (2020)

Article Respiratory System

Extracellular phosphate enhances the function of F508del-CFTR rescued by CFTR correctors

Vinciane Saint-Criq, Yiting Wang, Livia Delpiano, JinHeng Lin, David N. Sheppard, Michael A. Gray

Summary: The presence of extracellular phosphate modulates the function of rescued F508del-CFTR, likely involving electrogenic phosphate transport by SLC34A2. This effect impacts the magnitude of CFTR-mediated Cl- currents and may contribute to the variability in clinical response to CFTR correctors among individuals.

JOURNAL OF CYSTIC FIBROSIS (2021)

Article Chemistry, Medicinal

Into Deep Water: Optimizing BCL6 Inhibitors by Growing into a Solvated Pocket

Matthew G. Lloyd, Rosemary Huckvale, Kwai-Ming J. Cheung, Matthew J. Rodrigues, Gavin W. Collie, Olivier A. Pierrat, Mahad Gatti Iou, Michael Carter, Owen A. Davis, P. Craig McAndrew, Emma Gunnell, Yann-Vai Le Bihan, Rachel Talbot, Alan T. Henley, Louise D. Johnson, Angela Hayes, Michael D. Bright, Florence Raynaud, Mirco Meniconi, Rosemary Burke, Rob L. M. van Montfort, Olivia W. Rossanese, Benjamin R. Bellenie, Swen Hoelder

Summary: Optimization of modestly active starting points led to potent inhibitors of BCL6 by perturbing a water network and forming new interactions, ultimately achieving a 100-fold improvement in activity. The most potent compounds displaced three of the five initial water molecules and formed hydrogen bonds with the remaining two, showing promising inhibition of BCL6 in cells and satisfactory pharmacokinetic properties for compound 25.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Chemistry, Medicinal

Improved Binding Affinity and Pharmacokinetics Enable Sustained Degradation of BCL6 In Vivo

Rosemary Huckvale, Alice C. Harnden, Kwai-Ming J. Cheung, Olivier A. Pierrat, Rachel Talbot, Gary M. Box, Alan T. Henley, Alexis K. de Haven Brandon, Albert E. Hallsworth, Michael D. Bright, Hafize Aysin Akpinar, Daniel S. J. Miller, Dalia Tarantino, Sharon Gowan, Angela Hayes, Emma A. Gunnell, Alfie Brennan, Owen A. Davis, Louise D. Johnson, Selby de Klerk, Craig McAndrew, Yann-Vai Le Bihan, Mirco Meniconi, Rosemary Burke, Vladimir Kirkin, Rob L. M. van Montfort, Florence I. Raynaud, Olivia W. Rossanese, Benjamin R. Bellenie, Swen Hoelder

Summary: This study optimized a benzimidazolone molecular glue-type degrader, leading to the development of a highly potent probe CCT373566 for sustained depletion of BCL6. The research discovered a sharp degradation SAR and demonstrated the impact of subtle structural changes on the ability to induce degradation of BCL6. In a lymphoma xenograft mouse model, CCT373566 showed modest in vivo efficacy following oral dosing.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Chemistry, Medicinal

Optimizing Shape Complementarity Enables the Discovery of Potent Tricyclic BCL6 Inhibitors

Owen A. Davis, Kwai-Ming J. Cheung, Alfie Brennan, Matthew G. Lloyd, Matthew J. Rodrigues, Olivier A. Pierrat, Gavin W. Collie, Yann-Vai Le Bihan, Rosemary Huckvale, Alice C. Harnden, Ana Varela, Michael D. Bright, Paul Eve, Angela Hayes, Alan T. Henley, Michael D. Carter, P. Craig McAndrew, Rachel Talbot, Rosemary Burke, Rob L. M. van Montfort, Florence Raynaud, Olivia W. Rossanese, Mirco Meniconi, Benjamin R. Bellenie, Swen Hoelder

Summary: A new chemical series with enhanced binding affinity to the BTB domain of B-cell lymphoma 6 protein was identified by ring fusion onto a quinolinone lead series. This was achieved by attaining close shape complementarity and a conformationally restricted core, resulting in potent BCL6 inhibitors.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Physiology

Pharmacological inhibitors of the cystic fibrosis transmembrane conductance regulator exert off-target effects on epithelial cation channels

JinHeng Lin, Sean M. Gettings, Khaoula Talbi, Rainer Schreiber, Michael J. Taggart, Matthias Preller, Karl Kunzelmann, Mike Althaus, Michael A. Gray

Summary: Our study shows that two commonly used CFTR inhibitors, CFTRinh-172 and GlyH-101, significantly inhibit store-operated calcium entry (SOCE) at commonly used concentrations, and this inhibition is independent of CFTR. Patch clamp experiments demonstrate that both inhibitors can reduce SOCE by blocking the CRAC channel. In addition, these inhibitors have significant effects on human alpha beta gamma-ENaC-mediated currents in Xenopus oocytes, but their effects on delta beta gamma-ENaC function differ. Therefore, caution is needed when using these inhibitors to study the physiological role of CFTR and potentially ENaC.

PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2023)

Article Multidisciplinary Sciences

Discovering cell-active BCL6 inhibitors: effectively combining biochemical HTS with multiple biophysical techniques, X-ray crystallography and cell-based assays

Olivier A. Pierrat, Manjuan Liu, Gavin W. Collie, Kartika Shetty, Matthew J. Rodrigues, Yann-Vai Le Bihan, Emma A. Gunnell, P. Craig McAndrew, Mark Stubbs, Martin G. Rowlands, Norhakim Yahya, Erald Shehu, Rachel Talbot, Lisa Pickard, Benjamin R. Bellenie, Kwai-Ming J. Cheung, Ludovic Drouin, Paolo Innocenti, Hannah Woodward, Owen A. Davis, Matthew G. Lloyd, Ana Varela, Rosemary Huckvale, Fabio Broccatelli, Michael Carter, David Galiwango, Angela Hayes, Florence Raynaud, Christopher Bryant, Steven Whittaker, Olivia W. Rossanese, Swen Hoelder, Rosemary Burke, Rob L. M. van Montfort

Summary: By recruiting corepressor proteins, B-cell lymphoma 6 (BCL6) protein controls gene transcription required for B-cell germinal center formation. This study aims to discover small molecule inhibitors that disrupt BCL6-corepressor protein interaction, as BCL6 deregulation is implicated in Diffuse Large B-Cell Lymphoma development. The researchers used high throughput screening and various assays to identify hit series, determined X-ray structures of BCL6 bound to compounds, and developed biochemical and cellular assays to optimize compound potency.

SCIENTIFIC REPORTS (2022)

Article Chemistry, Medicinal

Discovery of an In Vivo Chemical Probe for BCL6 Inhibition by Optimization of Tricyclic Quinolinones

Alice C. Harnden, Owen A. Davis, Gary M. Box, Angela Hayes, Louise D. Johnson, Alan T. Henley, Alexis K. de Haven Brandon, Melanie Valenti, Kwai-Ming J. Cheung, Alfie Brennan, Rosemary Huckvale, Olivier A. Pierrat, Rachel Talbot, Michael D. Bright, Hafize Aysin Akpinar, Daniel S. J. Miller, Dalia Tarantino, Sharon Gowan, Selby de Klerk, Peter Craig McAndrew, Yann-Vai Le Bihan, Mirco Meniconi, Rosemary Burke, Vladimir Kirkin, Rob L. M. van Montfort, Florence I. Raynaud, Olivia W. Rossanese, Benjamin R. Bellenie, Swen Hoelder

Summary: In this study, we optimized our previously reported tricyclic quinolinone series to improve the cellular potency and in vivo exposure of the non-degrading isomer, leading to the discovery of a potent BCL6 inhibitor, CCT374705, with good in vivo profile.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

暂无数据